Just reading about the FDA’s response to Mesoblast and making Mesoblast go back retrial at the final hurdle. mSB share price has been hammered as a result. I don’t think it’s a given that the FDA will allow one trial for Invex either. Let’s see. Hope I’m wrong. I do agree about the comment re that they are stretched. The team is scattered all over the world and it’s small. has anyone contacted the company to get an update? I haven’t but wondering if anyone has some idea of what is going on over there?
IXC Price at posting:
97.0¢ Sentiment: Hold Disclosure: Held
